. . . . . . . . . "zavesca is a glucosylceramide synthase inhibitor indicated as monotherapy for treatment of adult patients with mild moderate type 1 gaucher disease for whom enzyme replacement therapy is not a therapeutic option 1 1 zavesca is a glucosylceramide synthase inhibitor indicated as monotherapy for the treatment of adult patients with mild to moderate type 1 gaucher disease for whom enzyme replacement therapy is not a therapeutic option e g due to allergy hypersensitivity or poor venous access" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "XOAIqFkoq52JqD6K6qApYRM+7Yj/gFHyd7C7fi0YBV07DzOvew9CTBALI3/s8KIKTn4JJmCrN0CZ/xPqqHql0enyPeD0nuVMF7b1gI/2jAEe3fKiwG+ZlpNmxrPmw9IqtBLkc2KjyqMJf2UjRJ0ishK8EBzkZ+XJneEJplTlUDw=" . . "2021-07-03T13:11:16.701+02:00"^^ . . . . .